No, not 21 deaths in the last 25 enrollments. i
Post# of 145825
i have made some posts today regarding the slide in todays deck that suggests 45 patients have died in the CD12 trial.
i thought that the large number of deaths was perhaps predictive of an efficacy stop in the CD12 trial, and from there i was trying to figure out what distriubution of the 45 deaths between the two arms might be.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)